Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Toyocamycin: phosphorylation and incorporation into RNA and DNA and the biochemical properties of the triphosphate.

× No keyword cloud information.

9 in total

1. Deciphering deazapurine biosynthesis: pathway for pyrrolopyrimidine nucleosides toyocamycin and sangivamycin.

Authors: Reid M McCarty; Vahe Bandarian
Journal: Chem Biol Date: 2008-08-25

Review 2. Biosynthesis of pyrrolopyrimidines.

Authors: Reid M McCarty; Vahe Bandarian
Journal: Bioorg Chem Date: 2012-01-31 Impact factor: 5.275

3. Synthesis and evaluation of an alkyne-modified ATP analog for enzymatic incorporation into RNA.

Authors: Yuxuan Zheng; Peter A Beal
Journal: Bioorg Med Chem Lett Date: 2016-02-18 Impact factor: 2.823

4. Identification of inhibitors of ribozyme self-cleavage in mammalian cells via high-throughput screening of chemical libraries.

Authors: Laising Yen; Maxime Magnier; Ralph Weissleder; Brent R Stockwell; Richard C Mulligan
Journal: RNA Date: 2006-03-23 Impact factor: 4.942

Review 5. Pyrrolo[2,3-d]pyrimidine (7-deazapurine) as a privileged scaffold in design of antitumor and antiviral nucleosides.

Authors: Pavla Perlíková; Michal Hocek
Journal: Med Res Rev Date: 2017-08-23 Impact factor: 12.944

6. A novel cell-based screening assay for small-molecule MYB inhibitors identifies podophyllotoxins teniposide and etoposide as inhibitors of MYB activity.

Authors: Maria Yusenko; Anke Jakobs; Karl-Heinz Klempnauer
Journal: Sci Rep Date: 2018-09-03 Impact factor: 4.379

7. Identification of a Biosynthetic Gene Cluster Responsible for the Production of a New Pyrrolopyrimidine Natural Product-Huimycin.

Authors: Hui Shuai; Maksym Myronovskyi; Suvd Nadmid; Andriy Luzhetskyy
Journal: Biomolecules Date: 2020-07-18

8. Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing.

Authors: M Ri; E Tashiro; D Oikawa; S Shinjo; M Tokuda; Y Yokouchi; T Narita; A Masaki; A Ito; J Ding; S Kusumoto; T Ishida; H Komatsu; Y Shiotsu; R Ueda; T Iwawaki; M Imoto; S Iida
Journal: Blood Cancer J Date: 2012-07-20 Impact factor: 11.037

9. Natural compounds' activity against cancer stem-like or fast-cycling melanoma cells.

Authors: Malgorzata Sztiller-Sikorska; Kamila Koprowska; Kinga Majchrzak; Mariusz Hartman; Malgorzata Czyz
Journal: PLoS One Date: 2014-03-03 Impact factor: 3.240

9 in total